A single dose improves fibre alignment and decreases scar tissue formation Targeted action improves quality of healing of tendon and suspensory ligament injuries in horses It takes years of diligent… Read More
Expands rare cannabinoid portfolio beyond current CBC and CBT Releases White Paper outlining research into the therapeutic potential of CBDV VANCOUVER, BC & SOUTH SAN FRANSISCO, CA – InMed Pharmaceuticals… Read More
VantAI will pair its induced proximity platform with BI’s deep early discovery experience to identify targeted protein degraders with enhanced properties for traditionally “undruggable” targets NEW YORK & INGELHEIM, GERMANY… Read More
KENILWORTH, N.J.– Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Joseph Romanelli will lead Human Health International, and join Merck’s Executive Team, effective… Read More
VICTORIA BC — Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX), a Phase 2 clinical-stage biotechnology company with an innovative drug delivery technology platform, today announced that it has… Read More
